Heart Capex To Depreciation from 2010 to 2024
| HSCS Stock | USD 3.83 0.41 11.99% |
Capex To Depreciation | First Reported 2010-12-31 | Previous Quarter 1.31679859 | Current Value 1.38 | Quarterly Volatility 0.42945991 |
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
Heart | Capex To Depreciation |
Latest Heart Test's Capex To Depreciation Growth Pattern
Below is the plot of the Capex To Depreciation of Heart Test Laboratories over the last few years. It is the ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets. Heart Test's Capex To Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
| Capex To Depreciation | 10 Years Trend |
|
Capex To Depreciation |
| Timeline |
Heart Capex To Depreciation Regression Statistics
| Arithmetic Mean | 0.35 | |
| Geometric Mean | 0.21 | |
| Coefficient Of Variation | 122.45 | |
| Mean Deviation | 0.31 | |
| Median | 0.18 | |
| Standard Deviation | 0.43 | |
| Sample Variance | 0.18 | |
| Range | 1.3588 | |
| R-Value | 0.63 | |
| Mean Square Error | 0.12 | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | 0.06 | |
| Total Sum of Squares | 2.58 |
Heart Capex To Depreciation History
About Heart Test Financial Statements
Heart Test shareholders use historical fundamental indicators, such as Capex To Depreciation, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capex To Depreciation | 1.32 | 1.38 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.